Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

HLA-DRA anticorps (CF®640R)

L’anticorps Souris Monoclonal anti-HLA-DRA a été validé pour FACS et IF. Il convient pour détecter HLA-DRA dans des échantillons de Humain et Singe.
N° du produit ABIN6153457

Aperçu rapide pour HLA-DRA anticorps (CF®640R) (ABIN6153457)

Antigène

Voir toutes HLA-DRA Anticorps
HLA-DRA (HLA Class II DR alpha (HLA-DRA))

Reactivité

  • 97
  • 16
  • 10
  • 9
  • 9
  • 9
  • 4
  • 3
  • 3
  • 1
Humain, Singe

Hôte

  • 62
  • 49
  • 4
  • 1
  • 1
Souris

Clonalité

  • 67
  • 50
Monoclonal

Conjugué

  • 60
  • 12
  • 7
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
Cet anticorp HLA-DRA est conjugé à/à la CF®640R

Application

  • 55
  • 52
  • 40
  • 34
  • 19
  • 16
  • 13
  • 10
  • 9
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunofluorescence (IF)

Clone

IPO-10
  • Fonction

    Mouse Monoclonal anti-MHC-II (HLA-DRA) (IPO-10), CF640R Conjugate

    Attributs du produit

    MAb IPO-10 defines the antigen, which appears on B cell progenitors following HLA-DR and preceding CD10, CD19, CD22, CD37 and cym. It is expressed on resting B cells and than reappears and persists in cytoplasm and on cell surface until cytoplasmic Ig appears. It is a useful antibody for diagnostics of neoplasms of B cell origins. It reacts with human B cell lines Daudi, Raji, Namalva, EB-3, RPMI-8226 (50 % of cells). The MAb does not label T cell lines, blood granulocytes, thymocytes or bone marrow stromal fibroblasts. No significant changes are detected after PHA or ConA stimulation while LPS and PWM stimulated cultures after 18-48h show decreased number of antigen-positive cells but in final terms of cultivation antigen is expressed again. This MAb labels B cell leukemias and some lymphomas. Hairy cell leukemia strongly reacts and 70 % of B cell CLL and some B-NHL were also positive. IPO-10 reacts with AMML cells and in a majority of Hodgkin's disease cases a significant percentage of affected lymph node cells were detected. Primary antibodies are available purified, or with a selection of fluorescent CF® dyes and other labels. CF® dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

    Immunogène

    Spleen cells of a patient with hairy cell leukemia (Daudi cells)

    Isotype

    IgG3 kappa
  • Indications d'application

    Immunofluorescence 0.5-1 μg/mL
    • Flow Cytometry 0.5-1 μg/million cells/0.1 mL
    • Optimal dilution for a specific application should be determined by user

    Commentaires

    Ramos, Daudi or HuT78 cells. Tonsil or lymph node

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    100 μg/mL

    Buffer

    PBS/0.1 % BSA/0.05 % azide

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    Protect from light
  • Antigène

    HLA-DRA (HLA Class II DR alpha (HLA-DRA))

    Autre désignation

    MHC-II (HLA-DRA)

    Poids moléculaire

    36 kDa

    ID gène

    3122, 520048

    UniProt

    P01903

    Pathways

    TCR Signaling, CXCR4-mediated Signaling Events, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Vous êtes ici:
Chat with us!